Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update

Go back to Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update
(NASDAQ: OCUL) Delayed: 10.14 +0.27 (2.74%)
Previous Close $9.87    52 Week High $14.50 
Open $10.11    52 Week Low $4.04 
Day High $10.55    P/E N/A 
Day Low $10.06    EPS $0.00 
Volume 2,311,152